AMSBIO has introduced human recombinant iMatrix Laminin 211 fragment for the purification and maintenance of cardiomyocytes in culture.
The Laminin family of glycoproteins are an integral part of the structural scaffolding in almost every tissue of an organism. They are secreted and incorporated into cell-associated extracellular matrices. Laminin is vital for the maintenance and survival of tissues. Defective Laminins can cause muscles to form improperly, leading to a form of muscular dystrophy, lethal skin blistering disease and defects of the kidney filter.
Laminin 211 is known to support the growth, survival, and differentiation of a wide range of tissue-specific cell types, including cardiac cells, skeletal muscle cells and motor neurons. As one of the main isoforms present in adult muscle tissue, Laminin 211 is critical for cardiomyocyte function and heart muscle development.
Proven to support functional cardiomyocytes and skeletal muscle cells culture, AMSBIO iMatrix Laminin-221 is a simple to use recombinant fragment that retains the full integrin-binding activity of Laminin-211.
The culture of iPSC derived heart and muscle cells under feed-free conditions requires the use of extracellular matrix proteins as an anchor to promote adherence and functionality. Laminin 211 fulfils this purpose through its binding of membrane bound integrin, and activation of intracellular signal cascades. The recombinant human iMatrix-211 is a high-quality matrix for basic research and drug development and toxicity studies with these critical cell types.
For further information on iMatrix Laminin 211 please visit http://www.amsbio.com/imatrix-recombinant-laminin-e8-fragments.aspx or contact the company on +44-1235-828200 / +1-617-945-5033 / email@example.com.
Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading transatlantic company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO has in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. This expertise in cell culture and the ECM allows AMSBIO to partner with clients in tailoring cell systems to enhance organoid and spheroid screening outcomes using a variety of 3D culture systems, including organ-on-a-chip microfluidics.
For drug discovery research, AMSBIO offers assays, recombinant proteins and cell lines. Drawing upon a huge and comprehensive biorepository, AMSBIO is widely recognised as a leading provider of high-quality tissue specimens (including custom procurement) from both human and animal tissues. The company provides unique clinical grade products for stem cell and cell therapy applications these include high quality solutions for viral delivery (lentivirus, adenovirus and adeno-associated virus) in addition to GMP cryopreservation technology.
Dr Bill Bradbury